DV
Dividend Vision

ONCY — Oncolytics Biotech Inc

Oncolytics Biotech Inc (ONCY)

Its deepest 1-year drawdown was 47.2%.

ONCY is an individual biotech stock rather than a diversified ETF. The company focuses on oncolytic virus research and development for cancer treatment applications. As a single-stock holding, it carries concentrated risk without dividend distributions, making it suited for growth-oriented investors with higher risk tolerance rather than income-focused portfolios.

ONCY key facts

Asset type
Stock
Asset class
Equity
Inception date
10/05/2001
Last close
$0.83
Market cap
$101,450,960
Average volume
1126800.0
Payment date
05/25/2018
Beta
1.095
Payout ratio
0.0
Forward P/E
45.4545
EPS
$-0.31